Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial

发表于 2026-8-5 16:59:35

期刊：Journal of Clinical Oncology

文献作者：Giorgio V. Scagliotti; Maciej Krzakowski; Aleksandra Szczesna; Janos Strausz; Anatoly Makhson; Martin Reck; Rafal F. Wierzbicki; Istvan Albert; Michael Thomas; Jose Elias Abrao Miziara; Zsolt S. Papai; Nina Karaseva; Sumitra Thongprasert; Elsa Dalmau Portulas; Joachim von Pawel; Ke Zhang; Paulina Selaru; Lesley Tye; Richard C. Chao; Ramaswamy Govindan

出版日期：2012-6-10

DOI号：10.1200/jco.2011.39.2993

下载链接：https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.39.2993

文献链接：https://doi.org/10.1200/jco.2011.39.2993

当前文献来源于 American Society of Clinical Oncology (ASCO)。

备注信息：

发表于 2026-8-5 16:59:36

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[ASCO] Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ASCO] Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial 一键复制